|
| Press Releases |
|
 |
|
| Wednesday, February 26, 2014 |
|
|
Cytokinetics Announces Closing of its Public Offering of Common Stock and Exercise of Option to Purchase Additional Shares |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today the closing of its previously announced underwritten public offering of 4,375,000 shares of its common stock, as well as 656,250 additional shares of its common stock pursuant to the full exercise of the underwriters' option to purchase additional shares. more info >> |
|
| Friday, February 21, 2014 |
|
|
Cytokinetics Announces pricing of $35.0 Million Public Offering of Common Stock |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today the pricing of its previously announced underwritten public offering of 4,375,000 shares of its common stock at a price to the public of $8.00 per share. more info >> |
|
| Thursday, February 20, 2014 |
|
|
Cytokinetics Announces Proposed Public Offering of Common Stock |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. more info >> |
|
| Friday, February 7, 2014 |
|
|
Cytokinetics, Incorporated Reports Fourth Quarter 2013 Financial Results |
| Cytokinetics, Incorporated (Nasdaq: CYTK) reported total revenues of $24.3 million for the fourth quarter of 2013, compared to $2.2 million during the same period in 2012. Net income for the fourth quarter was $6.5 million, or $0.22 per basic share and $0.21 per diluted share. more info >> |
|
| Wednesday, February 5, 2014 |
|
|
Cytokinetics to Present at Upcoming Healthcare Conferences |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that members of its management team are scheduled to participate at the following healthcare conferences. more info >> |
|
| Friday, January 24, 2014 |
|
|
Cytokinetics to Announce Fourth Quarter Results on February 6, 2014 |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it is scheduled to report fourth quarter results on Thursday, February 6, 2014 at 4:00 PM Eastern Time. more info >> |
|
| Monday, January 13, 2014 |
|
|
Cytokinetics Provides Updates Regarding Clinical Development Program for Omecamtiv Mecarbil |
| Cytokinetics, Incorporated (Nasdaq: CYTK) provided updates today regarding COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure) and other progress in the development of omecamtiv mecarbil. more info >> |
|
| Tuesday, December 10, 2013 |
|
|
Cytokinetics Announces Results from First-Time-In-Humans Clinical Trial of CK-2127107 at Conference of the Society on Sarcopenia, Cachexia and Wasting Disorders |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that the results from a first-time-in-humans clinical trial of CK-2127107 in healthy male volunteers were presented during a Late Breaking Clinical Trials session at the 7th International Conference of the Society on Sarcopenia, Cachexia and Wasting Disorders in Kobe, Japan. more info >> |
|
| Monday, December 9, 2013 |
|
|
Cytokinetics Announces Presentation Providing Update on BENEFIT-ALS at International Symposium on ALS/MND |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that a platform presentation of data from BENEFIT-ALS (Blinded Evaluation of Neuromuscular Effects and Functional Improvement with Tirasemtiv in ALS) was given at the 24th International Symposium on ALS/MND on December 7, 2013 in Milan, Italy. more info >> |
|
| Wednesday, December 4, 2013 |
|
|
Cytokinetics to Present Data Related to Skeletal Muscle Activators at Conference of Society on Sarcopenia, Cachexia and Wasting Disorders |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that two presentations, relating to its fast skeletal muscle troponin activators, are scheduled to be presented at the 7th International Conference of the Society on Sarcopenia, Cachexia and Wasting Disorders from December 9-11, 2013 in Kobe, Japan. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
国资护航+技术壁垒+优质保荐 华芢生物（02396.HK）PDGF管线直指18A赛道确定性价值
Dec 15, 2025 11:05 HKT/SGT
|
|
|
TransNusa Secures 19 Scheduled Flight Routes Within Three Years of Operations
Dec 15, 2025 09:51 HKT/SGT
|
|
|
國資護航+技術壁壘+優質保薦 華芢生物（02396.HK）PDGF管線直指18A賽道確定性價值
Dec 15, 2025 09:28 HKT/SGT
|
|
|
Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership
Dec 15, 2025 8:30 JST
|
|
|
韓国の主要人物・金載德氏がMOVA Chain支援を表明、エコシステム発展が新段階へ
Dec 13, 2025 13:00: JST
|
|
|
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST
|
|
|
京東工業登陸港交所：業績與品牌雙賦能 長期成長潛力可期
Dec 12, 2025 17:05 HKT/SGT
|
|
|
京东工业登陆港交所：业绩与品牌双赋能 长期成长潜力可期
Dec 12, 2025 17:04 HKT/SGT
|
|
|
京東工業配售結果出爐：MRO龍頭實力領跑 全鏈條數智化解決方案釋放長期價值
Dec 12, 2025 17:00 HKT/SGT
|
|
|
京东工业配售结果出炉：MRO龙头实力领跑 全链条数智化解决方案释放长期价值
Dec 12, 2025 17:00 HKT/SGT
|
|
|
全鏈條服務+業績高增長彰顯實力 京東工業港交所上市釋放長期價值
Dec 12, 2025 15:54 HKT/SGT
|
|
|
全链条服务+业绩高增长彰显实力 京东工业港交所上市释放长期价值
Dec 12, 2025 15:54 HKT/SGT
|
|
|
首隻山水實景表演概念股 印象大紅袍啟動香港公開募股
Dec 12, 2025 15:01 HKT/SGT
|
|
|
首只山水实景表演概念股 印象大红袍启动香港公开募股
Dec 12, 2025 15:00 HKT/SGT
|
|
|
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Dec 12, 2025 14:35 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
